|
Catalog Number
|
GTX101751
(
0
)
|
|
Product Name
|
MYH9 antibody [N1], N-term
|
| Applications | IHC-P, IP, WB |
| Application Note |
| Suggested dilution | Reference |
| IHC (Formalin-fixed paraffin-embedded sections) | 1:100-1:1000* |
|
| Immunoprecipitation | 1:100-1:500* |
|
| Western Blot (WB) | 1:500-1:3000* |
|
Not tested in other applications.
*Optimal dilutions/concentrations should be determined by the researcher.
|
| Predicted Target Size | 227 kDa (note)
|
| Positive Controls | U87-MG , SK-N-SH , IMR32 , SK-N-AS , NT2D1 , PC-3 |
| Form Supplied | Liquid |
| Concentration | 0.55
mg/ml
(Please refer to the vial label for the specific concentration) |
| Purification | Purified by antigen-affinity chromatography. |
| Full Name | myosin, heavy chain 9, non-muscle |
| Product Description | Rabbit Polyclonal antibody to MYH9 (myosin, heavy chain 9, non-muscle) |
| Background | This gene encodes a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq] |
| Synonyms | DFNA17 antibody, EPSTS antibody, FTNS antibody, MGC104539 antibody, MHA antibody, NMHC-II-A antibody, NMMHCA antibody, MYH9 antibody, myosin heavy chain 9 antibody, non-muscle myosin heavy chain IIa antibody, non-muscle myosin heavy chain A antibody, myosin-9 antibody, cellular myosin heavy chain, type A antibody, non-muscle myosin heavy polypeptide 9 antibody, myosin heavy chain, non-muscle IIa antibody, nonmuscle myosin heavy chain II-A antibody, myosin, heavy chain 9, non-muscle antibody |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | Recombinant protein encompassing a sequence within the N-terminus region of human MYH9. The exact sequence is proprietary. |
| Antigen Species | Human |
| Species Reactivity | Human |
Predicted Cross Reactivity species  Predicted cross-reactivity:
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
| Mouse, Rat, Xenopus laevis, Dog, Chicken, Bovine |
| Predict Reactivity Note | Mouse (98%), Rat (97%), Xenopus laevis (92%), Dog (99%), Chicken (96%), Bovine (99%) |
| Conjugation | Unconjugated |